US FDA Approves Zydus Lifesciences’ Tavaborole Topical Solution

Zydus Lifesciences Ltd., a Canadian pharmaceutical manufacturer, announced on Friday that the United States Food and Drug Administration (USFDA) has granted final approval for the production and distribution of Tavaborole Topical Solution 5%. According to the company’s exchange filing, Tavaborole topical solution is indicated for the treatment of fungal toenail infections, infections that can cause […]

Continue Reading